{
  "trial_id": "NCT02305381",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, baseline HbA1c, duration of diabetes, body mass index (BMI), baseline insulin dose, use of metformin, renal function (eGFR), history of hypoglycemia, history of pancreatitis, calcitonin levels, history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome 2 (MEN 2), history of acute coronary or cerebrovascular events, heart failure status (NYHA Class).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Glycosylated haemoglobin",
          "baseline HbA1c"
        ],
        [
          "Insulin dose",
          "baseline insulin dose"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Body weight",
        "Fasting plasma glucose",
        "Diastolic Blood Pressure",
        "Systolic Blood Pressure",
        "Diabetes Treatment Satisfaction Questionnaire"
      ],
      "remaining_candidate_features": [
        "duration of diabetes",
        "body mass index (BMI)",
        "use of metformin",
        "renal function (eGFR)",
        "history of hypoglycemia",
        "history of pancreatitis",
        "calcitonin levels",
        "history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome 2 (MEN 2)",
        "history of acute coronary or cerebrovascular events",
        "heart failure status (NYHA Class)"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline HbA1c, Duration of Diabetes, Body Mass Index, Basal Insulin Dose, Use of Metformin, Systolic Blood Pressure, Diastolic Blood Pressure, Estimated Glomerular Filtration Rate (eGFR), History of Severe Hypoglycemia,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Glycosylated haemoglobin",
          "Baseline HbA1c"
        ],
        [
          "Diastolic Blood Pressure",
          "Diastolic Blood Pressure"
        ],
        [
          "Systolic Blood Pressure",
          "Systolic Blood Pressure"
        ]
      ],
      "remaining_reference_features": [
        "Body weight",
        "Fasting plasma glucose",
        "Insulin dose",
        "Diabetes Treatment Satisfaction Questionnaire"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Duration of Diabetes",
        "Body Mass Index",
        "Basal Insulin Dose",
        "Use of Metformin",
        "Estimated Glomerular Filtration Rate (eGFR)",
        "History of Severe Hypoglycemia"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Diagnosis Duration, Basal Insulin Dose, Metformin Dose, HbA1c, BMI, Systolic Blood Pressure, Diastolic Blood Pressure, eGFR.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Glycosylated haemoglobin",
          "HbA1c"
        ],
        [
          "Insulin dose",
          "Basal Insulin Dose"
        ],
        [
          "Systolic Blood Pressure",
          "Systolic Blood Pressure"
        ],
        [
          "Diastolic Blood Pressure",
          "Diastolic Blood Pressure"
        ]
      ],
      "remaining_reference_features": [
        "Body weight",
        "Fasting plasma glucose",
        "Diabetes Treatment Satisfaction Questionnaire"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Diabetes Diagnosis Duration",
        "Metformin Dose",
        "BMI",
        "eGFR"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c at screening, fasting plasma glucose, systolic blood pressure, diastolic blood pressure, heart rate, smoking status, medical history (including cardiovascular disease, hypertension, dyslipidemia), concomitant medications, insulin dose, metformin dose, estimated glomerular filtration rate (eGFR).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Glycosylated haemoglobin",
          "HbA1c at screening"
        ],
        [
          "Fasting plasma glucose",
          "fasting plasma glucose"
        ],
        [
          "Systolic Blood Pressure",
          "systolic blood pressure"
        ],
        [
          "Diastolic Blood Pressure",
          "diastolic blood pressure"
        ],
        [
          "Insulin dose",
          "insulin dose"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Body weight",
        "Diabetes Treatment Satisfaction Questionnaire"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "body mass index (BMI)",
        "duration of type 2 diabetes",
        "heart rate",
        "smoking status",
        "medical history (including cardiovascular disease, hypertension, dyslipidemia)",
        "concomitant medications",
        "metformin dose",
        "estimated glomerular filtration rate (eGFR)"
      ]
    }
  }
}